|
|
|
Insider
Information: |
Stromatt Scott C |
Relationship: |
Chief Medical Officer ... |
City: |
Seattle |
State: |
WA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
216,183 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$27,974 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
216,183 |
|
|
Total
Value |
$27,974 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Aptevo Therapeutics Inc. |
APVO |
Chief Medical Officer ... |
2019-03-01 |
216,183 |
2017-02-03 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
13 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
APVO |
Aptevo Therapeutics Inc. |
Chief Medical Officer and SVP |
|
2019-03-01 |
4 |
D |
$1.57 |
$7,572 |
D/D |
(4,823) |
216,183 |
0 |
- |
|
APVO |
Aptevo Therapeutics Inc. |
Chief Medical Officer and SVP |
|
2019-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
16,269 |
221,006 |
0 |
- |
|
APVO |
Aptevo Therapeutics Inc. |
Chief Medical Officer and SVP |
|
2018-03-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,892 |
204,737 |
0 |
- |
|
APVO |
Aptevo Therapeutics Inc. |
Chief Medical Officer and SVP |
|
2018-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
16,269 |
190,845 |
0 |
- |
|
APVO |
Aptevo Therapeutics Inc. |
Chief Medical Officer and SVP |
|
2018-02-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
27,381 |
174,576 |
0 |
- |
|
APVO |
Aptevo Therapeutics Inc. |
Chief Medical Officer and SVP |
|
2017-08-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
78,123 |
147,195 |
0 |
- |
|
APVO |
Aptevo Therapeutics Inc. |
Chief Medical Officer and SVP |
|
2017-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
24,836 |
75,642 |
0 |
- |
|
APVO |
Aptevo Therapeutics Inc. |
Chief Medical Officer and SVP |
|
2017-03-10 |
4 |
D |
$1.78 |
$11,695 |
D/D |
(6,570) |
69,072 |
0 |
- |
|
APVO |
Aptevo Therapeutics Inc. |
Chief Medical Officer and SVP |
|
2017-03-09 |
4 |
D |
$1.80 |
$6,620 |
D/D |
(3,678) |
50,806 |
0 |
- |
|
APVO |
Aptevo Therapeutics Inc. |
Chief Medical Officer and SVP |
|
2017-03-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,902 |
54,484 |
0 |
- |
|
APVO |
Aptevo Therapeutics Inc. |
Chief Medical Officer and SVP |
|
2017-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
16,269 |
45,894 |
0 |
- |
|
APVO |
Aptevo Therapeutics Inc. |
Chief Medical Officer and SVP |
|
2017-03-01 |
4 |
D |
$2.02 |
$10,730 |
D/D |
(5,312) |
40,582 |
0 |
- |
|
APVO |
Aptevo Therapeutics Inc. |
Chief Medical Officer and SVP |
|
2017-02-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
27,381 |
29,625 |
0 |
- |
|
13 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|